This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
22 Sep 2011

India Forms 12 New Drug Advisory Committees

The 12 New Drug Advisory Committees will advise the Drugs Controller General of India in matters for review of applications of new drugs and clinical trials.

The Union health ministry of India has formed 12 New Drug Advisory Committees (NDAC) to advise the Drugs Controller General of India (DCGI) in matters for review of applications of new drugs and clinical trials.

 

Each of the panels set up to advise in matters related to review and regulatory approval of clinical trials and new drugs, except for Investigational New Drugs (INDs), relating to different therapeutic areas, has ten members.

 

The panels were formed on reproductive and urology, cardiovascular and renal, ophthalmology, vaccines, dermatology and allergy, anaesthetics and rheumatology, neurology and psychiatry, pulmonary, oncology and haematology, gastroenterology and hepatology, metabolism and endocrinology, and antimicrobial-antiparasitic-antifungal-antivir

Related News